Shopping Cart
Remove All
Your shopping cart is currently empty
Lacnotuzumab (Synonyms: MCS110, MCS 110, Anti-Human B7-H3)
Catalog No. T76868 Copy Product Info
🥰Excellent
Lacnotuzumab (MCS110) is a humanized monoclonal antibody targeting CSF-1, inhibiting the macrophage colony-stimulating factor pathway upstream components, used in retinal disease research.
Lacnotuzumab
Copy Product Info🥰Excellent
Catalog No. T76868
Synonyms MCS110, MCS 110, Anti-Human B7-H3
Lacnotuzumab (MCS110) is a humanized monoclonal antibody targeting CSF-1, inhibiting the macrophage colony-stimulating factor pathway upstream components, used in retinal disease research.
Lacnotuzumab
Cas No. 1831128-32-5
Customer service consultation
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $328 | In Stock | In Stock | |
| 5 mg | $1,160 | In Stock | In Stock | |
| 10 mg | $1,860 | - | In Stock | |
| 25 mg | $2,770 | - | In Stock | |
| 50 mg | $3,730 | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:99.36% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Lacnotuzumab (MCS110) is a humanized monoclonal antibody targeting CSF-1, inhibiting the macrophage colony-stimulating factor pathway upstream components, used in retinal disease research. |
| In vivo | Treatment of NOD/SCID mice with anti-human CSF-1 mAb Lacnotuzumab by subcutaneous injection of CHLA-255-Fluc NBs (given alone once weekly) reduced human monocyte-derived CD163 + cells but did not improve chemotherapy. [2] |
| Synonyms | MCS110, MCS 110, Anti-Human B7-H3 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | CSF1/M-CSF |
| Molecular Weight | 144.8 kDa |
| Cas No. | 1831128-32-5 |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | Store at low temperature | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy Lacnotuzumab | purchase Lacnotuzumab | Lacnotuzumab cost | order Lacnotuzumab | Lacnotuzumab in vivo | Lacnotuzumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.